Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2018

Genome-wide association meta-analysis in 269,867
individuals identifies new genetic and functional
links to intelligence
J. E. Savage
P. R. Jansen
S. Stringer
K. Watanabe
J. W. Trampush
Zucker School of Medicine at Hofstra/Northwell
See next page for additional authors

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Psychiatry Commons
Recommended Citation
Savage JE, Jansen PR, Stringer S, Watanabe K, Trampush JW, DeRosse P, Lencz T, Malhotra AK, Yu J, Posthuma D, . Genome-wide
association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. . 2018 Jan 01; 50(7):Article
4017 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/4017. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Authors

J. E. Savage, P. R. Jansen, S. Stringer, K. Watanabe, J. W. Trampush, P. DeRosse, T. Lencz, A. K. Malhotra, J. Yu,
D. Posthuma, and +107 additional authors

This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/4017

HHS Public Access
Author manuscript
Author Manuscript

Nat Genet. Author manuscript; available in PMC 2019 March 11.
Published in final edited form as:
Nat Genet. 2018 July ; 50(7): 912–919. doi:10.1038/s41588-018-0152-6.

Genome-wide association meta-analysis in 269,867 individuals
identifies new genetic and functional links to intelligence
A full list of authors and affiliations appears at the end of the article.

Author Manuscript

Intelligence is highly heritable1 and a major determinant of human health and well-being2.
Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in
intelligence3–7, but much about its genetic underpinnings remains to be discovered. Here, we
present the largest genetic association study of intelligence to date (N=269,867), identifying
205 associated genomic loci (190 novel) and 1,016 genes (939 novel) via positional
mapping, expression quantitative trait locus (eQTL) mapping, chromatin interaction
mapping, and gene-based association analysis. We find enrichment of genetic effects in
conserved and coding regions and associations with 146 nonsynonymous exonic variants.
Associated genes are strongly expressed in the brain, specifically in striatal medium spiny
neurons and hippocampal pyramidal neurons. Gene-set analyses implicate pathways related
to nervous system development and synaptic structure. We confirm previous strong genetic
correlations with multiple health-related outcomes, and Mendelian randomization results
suggest protective effects of intelligence for Alzheimer’s disease and ADHD, and
bidirectional causation with pleiotropic effects for schizophrenia. These results are a major
step forward in understanding the neurobiology of cognitive function as well as genetically
related neurological and psychiatric disorders.
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We performed a genome-wide association (GWAS) meta-analysis of 14 independent
epidemiological cohorts of European ancestry and 9,295,118 genetic variants passing quality
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control (Table 1; Supplementary Table 1; Supplementary Figure 1). A flowchart of the study
methodology is presented in Supplementary Figure 2 and additional details of the methods
and results are presented in the Supplementary Note.

Author Manuscript

Intelligence was assessed using various neurocognitive tests, primarily gauging fluid
domains of cognitive functioning (Supplementary Information 1.1–1.2). Despite variation in
form and content, cognitive test scores display a positive manifold of correlations, a robust
empirical phenomenon that is observed in multiple populations8. Statistically, the variance
common across cognitive tasks can be modeled as a latent factor denoted as g (the general
factor of intelligence)9,10. In addition, twin- and family studies show strong genetic
correlations across diverse cognitive domains11, suggesting pleiotropy, and across levels of
ability11, substantiating the view of general intelligence as an aetiological continuum (with
rare syndromic forms of severe intellectual disability being the exception12). Additionally, gfactors extracted from different sets of cognitive tests correlate very strongly (>.9813,14),
supporting the universality of g15,16. In meta-analyzing cognitive scores obtained using a
variety of tests, we aim to boost the statistical power to detect genetic variants underlying g,
which are likely to have pleiotropic effects across multiple domains of cognitive functioning.

Author Manuscript

Despite sample and methodological variations, genetic correlations (rg) between cohorts
were considerable (mean=0.67), and there was no evidence of heterogeneity between
cohorts in the single nucleotide polymorphism (SNP) associations (Supplementary Table 2;
Supplementary Results 2.1). Age-stratified meta-analyses indicated high genetic correlations
(rg>0.62), and comparable heritability across age, as captured by the SNPs included in the
analysis (h2SNP=0.19–0.22) (Supplementary Table 3; Supplementary Results 2.2). The full
sample h2SNP was 0.19 (SE=0.01), in line with previous findings4,5, and an LD score
intercept17 of 1.08 (SE=0.02) indicated that most of the inflation (λGC=1.92) could be
explained by polygenic signal6 (Supplementary Table 4; Supplementary Figure 3).

Author Manuscript

In the meta-analysis, 12,110 variants indexed by 242 lead SNPs in approximate linkage
equilibrium (r2<0.1) reached genome-wide significance (GWS; P<5×10−8) (Figure 1a;
Supplementary Tables 5–7; Supplementary Figures 4–5). These were located in 205 distinct
genomic loci (Supplementary Results 2.3.1). We tested for replication using the proxy
phenotype of educational attainment, which is correlated phenotypically (r=~0.40)18 and
genetically (r=~0.70)19 with intelligence. We confirmed this high genetic correlation
(rg=0.73) and observed sign concordance with educational attainment for 93% of GWS
SNPs (P<1×10−300), with replication for 48 loci (Supplementary Results 2.3.2;
Supplementary Table 8). Using polygenic score prediction20,21, the current results explain
up to 5.2% of the variance in intelligence in four independent samples (Supplementary Table
9, Supplementary Results 2.3.3).
We observed enrichment for heritability of SNPs in conserved regions (P=2.01×10−12),
coding regions (P=1.67×10−6), and H3K9ac histone regions/peaks (P<6.26×10−5), and
among common (minor allele frequency > 0.3) variants (Figure 1b; Supplementary Results
2.3.4; Supplementary Table 10; Supplementary Figures 6–7). Conserved and regulatory
regions have previously been implicated in cognitive functioning22 but coding regions have
not.
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Functional annotation of all candidate SNPs in the associated loci (SNPs with an r2≧0.6 with
one of the independent significant SNPs, a suggestive P-value (P<1×10−5) and a
MAF>0.0001; n=21,368) showed that these were mostly intronic/intergenic (Supplementary
Table 6; Figure 1), yet 146 (81 GWS) SNPs were exonic non-synonymous (ExNS)
(Supplementary Table 11, Supplementary Results 2.3.5). Convergent evidence of strong
association (Z=9.49) and the highest observed probability of a deleterious protein effect
(CADD23 score=34) was found for rs13107325. This missense mutation (MAF=0.065,
P=2.23×10−21) in SLC39A8 was the lead SNP in locus 71 and the ancestral allele C was
associated with higher scores on intelligence measures. The effect sizes for ExNS were
individually small, with each effect allele accounting for a difference of 0.01 to 0.08
standard deviations. Supplementary Tables 6 and 11 and Supplementary Results 2.3.5
present a detailed catalog of variants in the associated genomic loci.

Author Manuscript
Author Manuscript

To link the associated variants to genes, we applied three gene-mapping strategies
implemented in FUMA24. Positional gene-mapping aligned SNPs to 522 genes by genomic
location, eQTL (expression quantitative trait loci) gene-mapping matched cis-eQTL SNPs to
684 genes whose expression levels they influence, and chromatin interaction mapping
annotated SNPs to 227 genes based on three-dimensional DNA-DNA interactions (Figure 2;
Supplementary Results 2.3.6; Supplementary Figures 8–9; Supplementary Tables 12–14).
This resulted in 859 unique mapped genes, 435 of which were implicated by at least two
mapping strategies and 139 by all three (Figure 3). Although not all of these genes are
certain to have a role in intelligence, they point to potential functional links for the GWAS
associated variants and give higher credibility to genes with convergent evidence of
association from multiple sources. The FUMA-mapped genes were enriched for brain tissue
expression and several regulatory biological gene-sets (Supplementary Results 2.3.6).
Fifteen genes are particularly notable as they are implicated via chromatin interactions
between two independent genomic risk loci (Figure 2; Supplementary Results 2.3.6). Crosslocus interactions implicated ELAVL2, PTCH1, ATF4, FBXL17, and MAN2A1 in left
ventricle of the heart tissue, SATB2 in liver tissue, and MEF2C in 5 tissues. Multiple
interactions in multiple tissue types were seen for a cluster of 8 genes on chromosome 6
encoding zinc finger proteins and histones.
We performed genome-wide gene-based association analysis (GWGAS) using MAGMA25
to estimate aggregate associations based on all SNPs in a gene (whereas FUMA annotates
individually significant SNPs to genes). GWGAS identified 507 associated genes (Figure 3a;
Supplementary Results 2.4.1; Supplementary Table 15), of which 350 were also mapped by
FUMA (Figure 3b). In total, 105 genes were implicated by all four strategies
(Supplementary Table 16).

Author Manuscript

In gene-set analysis, six Gene Ontology26 gene-sets were significantly associated with
intelligence: neurogenesis (P=4.78×10−7), neuron differentiation (P=4.82×10−6), central
nervous system neuron differentiation (P=3.31×10−6), regulation of nervous system
development (P=9.30×10−7), positive regulation of nervous system development
(P=1.00×10−6), and regulation of synapse structure or activity (P=5.42×10−6)
(Supplementary Results 2.4.2; Supplementary Tables 17–18). Conditional analysis indicated
that there were three independent associations, regulation of nervous system development,
Nat Genet. Author manuscript; available in PMC 2019 March 11.
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central nervous system neuron differentiation, and regulation of synapse structure or activity,
which together accounted for the associations of the other sets.
Linking gene-based P-values to tissue-specific gene-sets, we observed strong associations
with gene expression across multiple brain areas (Figure 3c; Supplementary Results 2.4.2;
Supplementary Table 19), particularly the frontal cortex (P=3.10×10−9). In brain single-cell
expression gene-set analyses, we found significant associations of striatal medium spiny
neurons (P=2.02×10−14) and pyramidal neurons in the CA1 hippocampal (P=5.67×10−11)
and cortical somatosensory regions (P=2.72×10−9) (Figure 3d; Supplementary Results 2.4.2;
Supplementary Table 20). Conditional analysis showed that the independent association
signal in brain cells was driven by medium spiny neurons, neuroblasts, and pyramidal CA1
neurons.

Author Manuscript

Intelligence has been associated with a wide variety of human behaviors15 and brain
anatomy27. Confirming previous reports5,6, we observed negative genetic correlations with
ADHD (rg=−0.36, P=4.58×10−23), depressive symptoms (rg=−0.27, P=6.20×10−10),
Alzheimer’s disease (rg=−0.27, P=2.03×10−5), and schizophrenia (rg=−0.21, P=3.82×10−17),
and positive correlations with longevity (rg=0.43, P=7.96×10−8) and autism (rg=0.25,
P=3.14×10−7), among others (Supplementary Table 21; Supplementary Figure 10).
Comparison with previous GWAS28 supported these correlations, showing numerous shared
genetic variants across phenotypes (Supplementary Results 2.5; Supplementary Tables 22–
23). Low enrichment (87 of 1,518 genes, P=0.05) was found for genes previously linked to
intellectual disability or developmental delay, indicating largely distinct biological
processes. However, our results extend previous genetic research on normal variation in
general intelligence, as catalogued in Supplementary Tables 24–25.

Author Manuscript
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We used Generalized Summary-statistic-based Mendelian Randomization29 to test for
potential credible causal associations between intelligence and genetically correlated traits
(Supplementary Results 2.5.3; Supplementary Figures 11–12; Supplementary Table 26). We
observed a strong bidirectional effect of cognitive ability on educational attainment
(bxy=0.549, P<1×10−320) and of educational attainment on intelligence (byx=0.480,
P=6.85×10−82). Such findings are consistent with previous studies implicating bidirectional
causal effects30,31. There was also a bidirectional association showing a strong protective
effect of intelligence on schizophrenia (OR=0.50, bxy=−0.685, P=2.02×10−57) and a
relatively smaller reverse effect (byx= −0.214, P=4.19×10−52), with additional evidence for
pleiotropy (Supplementary Results 2.5.3). A number of previous reports support both a
causal link and genetic overlap between these phenotypes32,33. Our results also suggested
that higher intelligence had a protective effect on ADHD (OR=0.48, bxy=−0.734,
P=2.57×10−46) and Alzheimer’s disease (OR=0.65, bxy=−0.435, P=3.59×10−14), but was
associated with higher risk of autism (OR=1.38, bxy=0.321, P=1.12×10−3).
In the present study, we have affirmed and expanded existing knowledge of the genetics of
general intelligence, identifying 190 novel loci and 939 novel associated genes and
replicating previous associations with 15 loci and 77 genes. The combined strategies of
functional annotation and gene-mapping using biological data resources provide extensive
information on the likely consequences of relevant genetic variants and put forward a rich
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set of plausible gene targets and biological mechanisms for functional follow-up. Gene-set
analyses contribute novel insight into underlying neurobiological pathways, confirming the
importance of brain-expressed genes and neurodevelopmental processes in fluid domains of
intelligence and pointing towards the involvement of specific cell types. Our results indicate
overlap in the genetic processes involved in both cognitive functioning and neurological and
psychiatric traits and provide suggestive evidence of causal associations that may drive these
correlations. These results are important for understanding the biological underpinnings of
cognitive functioning and contribute to our understanding of related neurological and
psychiatric disorders.

Online Methods
Study Cohorts

Author Manuscript

The meta-analysis included new and previously reported GWAS summary statistics from 14
cohorts: UK Biobank (UKB), Cognitive Genomics Consortium (COGENT), Rotterdam
Study (RS), Generation R Study (GENR), Swedish Twin Registry (STR), Spit for Science
(S4S), High-IQ/Health and Retirement Study (HiQ/HRS), Twins Early Development Study
(TEDS), Danish Twin Registry (DTR), IMAGEN, Brisbane Longitudinal Twin Study
(BLTS), Netherlands Study of Cognition, Environment and Genes (NESCOG), Genes for
Good (GfG), and the Swedish Twin Studies of Aging (STSA). All samples were obtained
from epidemiological cohorts ascertained for research on a variety of physical and
psychological outcomes. Participants ranged from children to older adults, with older
samples being screened for cognitive decline to exclude the possibility of dementia affecting
performance on cognitive tests.

Author Manuscript
Author Manuscript

Different measures of intelligence were assessed in each cohort but were all operationalized
to index a common latent g factor underlying multiple dimensions of cognitive functioning.
With the exception of HiQ/HRS, all cohorts extracted a single sum score, mean score, or
factor score from a multidimensional set of cognitive performance tests and used this
normally-distributed score as the phenotype in a covariate-adjusted (e.g. age, sex, ancestry
principal components) GWAS using linear regression methods. For HiQ/HRS, a logistic
regression GWAS was run with “case” status reflecting whether participants were drawn
from an extreme-sampled population of very high intelligence (i.e. at the upper ~0.03% of
the tail of the normal distribution) versus an epidemiological sample of unselected
population “controls”. Detailed descriptions of the samples, measures, genotyping, quality
control, and analysis procedures for each cohort are provided in the Supplementary Note
(Supplementary Information 1.1–1.2), Supplementary Table 1, and in the Life Sciences
Reporting Summary.
Meta-analysis
Stringent quality control measures were applied to the summary statistics for each GWAS
cohort before combining. All files were checked for data integrity and accuracy. SNPs were
filtered from further analysis if they met any of the following criteria: imputation quality
(INFO/R2) score < 0.6, Hardy-Weinberg equilibrium (HWE) P < 5×10−6, study-specific
minor allele frequency (MAF) corresponding to a minor allele count (MAC) < 100, and
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mismatch of alleles or allele frequency difference greater than 20% from the Haplotype
Reference Consortium (HRC) genome reference panel16. Some cohorts used more stringent
criteria (see Supplementary Information 1.1). Indels and SNPs that were duplicated, multiallelic, monomorphic, or ambiguous (A/T or C/G with a MAF >0.4) were also excluded.
Visual inspection of the distribution of the summary statistics was completed, and
Manhattan plots and QQ plots were created for the cleaned summary statistics from each
cohort (Supplementary Figure 1).

Author Manuscript

The SNP association P-values from the GWAS cohorts were meta-analyzed with METAL34
(see URLs) in two phases. First, we meta-analyzed all cohorts with quantitative phenotypes
(all except HiQ/HRS) using a sample-size weighted scheme. In the second phase, we added
the HiQ/HRS study results to the first phase results, weighting each set of summary statistics
by their respective non-centrality parameter (NCP). This method improves power when
using an extreme case sampling design such as HiQ35 and provides a comparable metric
with which to combine information from different analytic designs while accounting for
their differences in power/effective sample size. NCPs were estimated using the Genetic
Power Calculator36, as described by Coleman et al.37. After combining all data, metaanalysis results were further filtered to exclude any variants with N < 50,000. We
additionally included a random-effects meta-analysis for each phase, as implemented in
METAL, to evaluate potential heterogeneity in the SNP association statistics between
cohorts.

Author Manuscript

The X chromosome was treated separately in the meta-analysis because imputed genotypes
were not available for the X chromosome in the largest cohort (UKB), and there was little
overlap between the UKB called genotypes and imputed data from other cohorts (NSNPs <
500). We therefore included only the called X chromosome variants in UKB for these
analyses after performing X-specific quality control steps38.
We conducted a series of meta-analyses on subsets of the full sample using the same
methods as above. Age group-specific meta-analyses were run in the cohorts of children
(age < 17; GENR, TEDS, IMAGEN, BLTS; N=9,814), young adults (age ~17–18; S4S,
STR; N=6,033), adults (age > 18, primarily middle-aged or older: UKB, RS, DTR,
NESCOG, STSA; N=204,228), and older adults (mean age > 60, RS, DTR, STSA;

Author Manuscript

URLs:
UK Biobank website: http://ukbiobank.ac.uk
UK Biobank genotyping: http://www.biorxiv.org/content/early/2017/07/20/166298
Health and Retirement study: http://hrsonline.isr.umich.edu
Genes for Good study: http://genesforgood.org
International Cognitive Ability Resource measure (Genes for Good): https://icar-project.com/
Functional Mapping and Annotation (FUMA) software: http://fuma.ctglab.nl
Multi-marker Analysis of GenoMic Annotation (MAGMA) software: http://ctg.cncr.nl/software/magma
METAL software: http://genome.sph.umich.edu/wiki/METAL_Program
LD Score Regression software: https://github.com/bulik/ldsc
LD Hub (GWAS summary statistics): http://ldsc.broadinstitute.org/
LD scores: https://data.broadinstitute.org/alkesgroup/LDSCORE/
GeneCards: http://www.genecards.org
Psychiatric Genomics Consortium (GWAS summary statistics): http://www.med.unc.edu/pgc/results-and-downloads
MSigDB curated gene-set database: http://software.broadinstitute.org/gsea/msigdb/collections.jsp
NHGRI GWAS catalog: https://www.ebi.ac.uk/gwas/
RegionAnnotator: https://github.com/ivankosmos/RegionAnnotator
Generalized Summary-data-based Mendelian Randomization software: http://cnsgenomics.com/software/gsmr/

Nat Genet. Author manuscript; available in PMC 2019 March 11.

Savage et al.

Page 7

Author Manuscript

N=8,323), excluding studies whose samples overlapped child/young adult and adult groups
(COGENT, HiQ/HRS, GfG; N=49,792). To create independent discovery samples for use in
polygenic score validation, we also conducted meta-analyses with a “leave-one-out” strategy
in which summary statistics from four validation datasets were, respectively, excluded from
the meta-analysis (see Polygenic Scoring, below).
Cohort Heritability and Genetic Correlation

Author Manuscript

LD score regression17 was used to estimate genomic inflation and heritability of the
intelligence phenotypes in each of the 14 cohorts using their post-quality control summary
statistics, and to estimate the cross-cohort genetic correlations39. Pre-calculated LD scores
from the 1000 Genomes European reference population were obtained online (see URLs).
Genetic correlations were calculated on HapMap3 SNPs only. LD score regression was also
used on the age subgroup meta-analyses to estimate heritability and cross-age genetic
correlations.
Genomic Risk Loci Definition

Author Manuscript

Independently associated loci from the meta-analysis were defined using FUMA24 (see
URLs), an online platform for functional mapping of genetic variants. We first identified
independent significant SNPs which had a Bonferroni-corrected genome-wide significant
two-tailed P-value (P<5×10−8) and represented signals that were independent from each
other at r2<0.6. These SNPs were further represented by lead SNPs, which are a subset of
the independent significant SNPs that are in approximate linkage equilibrium with each
other at r2<0.1. We then defined associated genomic loci by merging any physically
overlapping lead SNPs (linkage disequilibrium [LD] blocks <250kb apart). Borders of the
associated genomic loci were defined by identifying all SNPs in LD (r2≧0.6) with one of the
independent significant SNPs in the locus, and the region containing all of these candidate
SNPs was considered to be a single independent genomic locus. All LD information was
calculated from UK Biobank genotype data.
Proxy-replication with Educational Attainment

Author Manuscript

We conducted GWAS of educational attainment, an outcome with a high genetic correlation
with intelligence5, in a non-overlapping European subset of the UKB sample (N=188,435)
who did not complete the intelligence measure. Educational attainment was coded as
maximum years of education completed, using the same methods as earlier analyses40 and
GWAS was conducted using the same quality control and analytic procedures as described
for the UKB intelligence phenotype (Supplementary Information 1.1.1). To test replication
of the SNPs with this proxy phenotype, we performed a sign concordance test for all GWS
SNPs from the meta-analysis using the two-tailed exact binomial test. For each independent
genomic locus, we considered it to be evidence for replication if the lead SNP or another
correlated SNP in the region was sign concordant with the corresponding SNP in the
intelligence meta-analysis and had a two-tailed P-value of association with educational
attainment smaller than 0.05/242 independent tests=0.0002.
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We calculated polygenic scores (PGS) based on the SNP effect sizes of the leave-one-out
meta-analyses, from which four cohorts were (separately) excluded and reserved for score
validation. These included a child (GENR), young adult (S4S), and adult sample (RS). We
also included the UKB-wb sample to test for validation in a very large (N = 53,576) cohort
with the greatest phenotypic similarity to the largest contributor to the meta-analysis
statistics (UKB-ts), in order to maximize potential predictive power. PGS were calculated on
the genotype data using LDpred21, a Bayesian PGS method that utilizes a prior on effect size
distribution to remodel the SNP effect size and account for LD, and PRSice20, a PLINK41based program that automates optimization of the set of SNPs included in the PGS based on
a high-resolution filtering of the GWAS P-value threshold. LDpred PGS were applied to the
called, cleaned, genotyped variants in each of the validation cohorts with UK Biobank as the
LD reference panel. PRSice PGS were calculated on hard-called imputed genotypes using Pvalue thresholds from 0.0 to 0.5 in steps of 0.001. The explained variance (ΔR2) was derived
from a linear model in which the GWAS intelligence phenotype was regressed on each PGS
while controlling for the same covariates as in each cohort-specific GWAS, compared to a
linear model with GWAS covariates only.
Stratified Heritability

Author Manuscript

We partitioned SNP heritability using stratified LD Score regression42 in three ways: 1) by
functional annotation category, 2) by minor allele frequency (MAF) in six percentile bins,
and 3) by chromosome. Annotations for 28 binary categories of putative functional genomic
characteristics (e.g. coding or regulatory regions) were obtained from the LD score website
(see URLs). With this method, enrichment/depletion of heritability in each category is
calculated as the proportion of heritability attributable to SNPs in the specified category
divided by the proportion of total SNPs annotated to that category. The Bonferroni-corrected
significance threshold was .05/56 annotations=.0009.
Functional Annotation of SNPs

Author Manuscript

Functional annotation of SNPs implicated in the meta-analysis was performed using
FUMA24 (see URLs). We selected all candidate SNPs in associated genomic loci having an
r2≧0.6 with one of the independent significant SNPs (see above), a suggestive P-value
(P<1e-5) and a MAF>0.0001 for annotations. Predicted functional consequences for these
SNPs were obtained by matching SNPs’ chromosome, base-pair position, and reference and
alternate alleles to databases containing known functional annotations, including
ANNOVAR43 categories, Combined Annotation Dependent Depletion (CADD) scores23,
RegulomeDB44 (RDB) scores, and chromatin states45,46. ANNOVAR categories identify the
SNP’s genic position (e.g. intron, exon, intergenic) and associated function. CADD scores
predict how deleterious the effect of a SNP is likely to be for a protein structure/function,
with higher scores referring to higher deleteriousness. A CADD score above 12.37 is the
threshold to be potentially pathogenic23. The RegulomeDB score is a categorical score based
on information from expression quantitative trait loci (eQTLs) and chromatin marks, ranging
from 1a to 7 with lower scores indicating an increased likelihood of having a regulatory
function. Scores are as follows: 1a=eQTL + Transcription Factor (TF) binding + matched TF
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motif + matched DNase Footprint + DNase peak; 1b=eQTL + TF binding + any motif +
DNase Footprint + DNase peak; 1c=eQTL + TF binding + matched TF motif + DNase peak;
1d=eQTL + TF binding + any motif + DNase peak; 1e=eQTL + TF binding + matched TF
motif; 1f=eQTL + TF binding / DNase peak; 2a=TF binding + matched TF motif + matched
DNase Footprint + DNase peak; 2b=TF binding + any motif + DNase Footprint + DNase
peak; 2c=TF binding + matched TF motif + DNase peak; 3a=TF binding + any motif +
DNase peak; 3b=TF binding + matched TF motif; 4=TF binding + DNase peak; 5=TF
binding or DNase peak; 6=other; 7=Not available. The chromatin state represents the
accessibility of genomic regions (every 200bp) with 15 categorical states predicted by a
hidden Markov model based on 5 chromatin marks for 127 epigenomes in the Roadmap
Epigenomics Project46. A lower state indicates higher accessibility, with states 1–7 referring
to open chromatin states. We annotated the minimum chromatin state across tissues to SNPs.
The 15-core chromatin states as suggested by Roadmap are as follows: 1=Active
Transcription Start Site (TSS); 2=Flanking Active TSS; 3=Transcription at gene 5’ and 3’;
4=Strong transcription; 5= Weak Transcription; 6=Genic enhancers; 7=Enhancers; 8=Zinc
finger genes & repeats; 9=Heterochromatic; 10=Bivalent/Poised TSS; 11=Flanking Bivalent/
Poised TSS/Enhancer; 12=Bivalent Enhancer; 13=Repressed PolyComb; 14=Weak
Repressed PolyComb; 15=Quiescent/Low. Standardized SNP effect sizes were calculated for
the most impactful SNPs by transforming the sample size-weighted meta-analysis Z score,
as described by Zhu et al.47.
Gene-mapping
Genome-wide significant loci obtained by the GWAS meta-analysis were mapped to genes
in FUMA24 using three strategies:

Author Manuscript
Author Manuscript

1.

Positional mapping maps SNPs to genes based on physical distance (within a
10kb window) from known protein coding genes in the human reference
assembly (GRCh37/hg19).

2.

eQTL mapping maps SNPs to genes with which they show a significant eQTL
association (i.e. allelic variation at the SNP is associated with the expression
level of that gene). eQTL mapping uses information from 45 tissue types in 3
data repositories (GTEx48, Blood eQTL browser49, BIOS QTL browser50), and
is based on cis-eQTLs which can map SNPs to genes up to 1Mb apart. We used a
false discovery rate (FDR) of 0.05 to define significant eQTL associations.

3.

Chromatin interaction mapping was performed to map SNPs to genes when there
is a three-dimensional DNA-DNA interaction between the SNP region and a
gene region. Chromatin interaction mapping can involve long-range interactions
as it does not have a distance boundary. FUMA currently contains Hi-C data of
14 tissue types from the study of Schmitt et al51. Since chromatin interactions are
often defined in a certain resolution, such as 40kb, an interacting region can span
multiple genes. If a SNPs is located in a region that interacts with a region
containing multiple genes, it will be mapped to each of those genes. To further
prioritize candidate genes, we selected only interaction-mapped genes in which
one region involved in the interaction overlaps with a predicted enhancer region
in any of the 111 tissue/cell types from the Roadmap Epigenomics Project46 and
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the other region is located in a gene promoter region (250bp up and 500bp
downstream of the transcription start site and also predicted by Roadmap to be a
promoter region). This reduces the number of genes mapped but increases the
likelihood that those identified will have a plausible biological function. We used
a FDR of 1×10−5 to define significant interactions, based on previous
recommendations51 modified to account for the differences in cell lines used
here.
Functional annotation of mapped genes

Author Manuscript

Genes implicated by mapping of significant GWAS SNPs were further investigated using the
GENE2FUNC procedure in FUMA24, which provides hypergeometric tests of enrichment of
the list of mapped genes in 53 GTEx48 tissue-specific gene expression sets, 7,246 MSigDB
gene-sets52, and 2,195 GWAS catalog gene-sets28. The Bonferroni-corrected significance
threshold was 0.05/9,494 gene-sets=5.27×10-6.
Gene-based analysis
SNP-based P-values from the meta-analysis were used as input for the gene-based genomewide association analysis (GWGAS). 18,128 protein-coding genes (each containing at least
1 GWAS SNP) from the NCBI 37.3 gene definitions were used as basis for GWGAS in
MAGMA25 (see URLs). The Bonferroni-corrected genome-wide significance threshold
was .05/18,128 genes=2.76×10-6.
Gene-set analysis

Author Manuscript

Results from the GWGAS analyses were used to test for association in three types of
predefined gene-sets:

Author Manuscript

1.

7,246 curated gene-sets representing known biological and metabolic pathways
were derived from 9 data resources, catalogued by and obtained from the
MsigDB version 5.229 (see URLs)

2.

gene expression values from 53 tissues obtained from GTEx48, log2 transformed
with pseudocount 1 after winsorization at 50 and averaged per tissue

3.

cell-type specific gene expression in 24 types of brain cells, which were
calculated following the method described in Skene et al.53 and Coleman et al.37
Briefly, brain cell-type expression data was drawn from single-cell RNA
sequencing data from mouse brains. For each gene, the value for each cell-type
was calculated by dividing the mean Unique Molecular Identifier (UMI) counts
for the given cell type by the summed mean UMI counts across all cell types.
Single-cell gene-sets were derived by grouping genes into 40 equal bins by
specificity of expression.

These gene-sets were tested for association with the GWGAS gene-based test statistics using
MAGMA. We computed competitive P-values, which represent the test of association for a
specific gene-set compared to other gene-sets. This method is more robust to Type I error
than self-contained tests that only test for association of a gene-set against the null
hypothesis of no association25. The Bonferroni-corrected significance threshold was
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0.05/7,323 gene-sets=6.83×10-6. Conditional analyses were performed as a follow-up using
MAGMA to test whether each significant association observed was independent of all
others. The association between each gene-set was tested conditional on the most strongly
associated set, and then - if any substantial (p<.05/number of gene-sets) associations
remained - by conditioning on the first and second most strongly associated set, and so on
until no associations remained. Gene-sets that retained their association after correcting for
other sets were considered to be independent signals. We note that this is not a test of
association per se, but rather a strategy to identify, among gene-sets with known significant
associations whose defining genes may overlap, which set(s) are responsible for driving the
observed association.
Cross-Trait Genetic Correlation

Author Manuscript

Genetic correlations (rg) between intelligence and 38 phenotypes were computed using LD
score regression39, as described above, based on GWAS summary statistics obtained from
publicly available databases (see URLs; Supplementary Table 18). The Bonferroni-corrected
significance threshold was 0.05/38 traits=1.32×10-3.
GWAS catalog lookup

Author Manuscript

We used FUMA to identify SNPs with previously reported (P < 5×10−5) phenotypic
associations in published GWAS listed in the NHGRI-EBI catalog28 which overlapped with
the genomic risk loci identified in the meta-analysis. As an additional relevant phenotype of
interest, we examined whether the genes associated with intelligence in this study (by
FUMA mapping or GWGAS) were overrepresented in a set of 1,518 genes linked to
intellectual disability and/or developmental delay, as compiled by RegionAnnotater (see
URLs). Many of these have been identified by non-GWAS sources and are not represented
in the NHGRI catalog. We tested for enrichment using a hypergeometric test with a
background set of 19,283 genomic protein-coding genes, as in FUMA. Manual lookups were
also performed to identify overlapping loci/genes with known previous GWAS of
intelligence.
Mendelian Randomization
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To infer credible causal associations between intelligence and traits that are genetically
correlated with intelligence, we performed Generalized Summary-data based Mendelian
Randomization29 (GSMR; see URLs). This method utilizes summary-level data to test for
causal associations between a putative risk factor (exposure) and an outcome by using
independent genome-wide significant SNPs as instrumental variables. HEIDI-outlier
detection was used to filter genetic instruments that show clear pleiotropic effects on both
the exposure phenotype and the outcome phenotype. We used a threshold p-value of 0.01 for
the outlier detection analysis in HEIDI which removes 1% of SNPs by chance if there is no
pleiotropic effect. To test for a potential causal effect of intelligence on various outcomes,
we selected traits in non-overlapping samples that showed significant genetic correlations
(rg) with intelligence. We tested for bi-directional causation by repeating the analyses while
switching the role of each correlated phenotype as an exposure and intelligence as the
outcome. For each trait, we selected independent (r2=<0.1), GWS lead SNPs as instrumental
variables in the analyses. For traits with less than 10 GWS lead SNPs (i.e. the minimum
Nat Genet. Author manuscript; available in PMC 2019 March 11.

Savage et al.

Page 12

Author Manuscript

number of SNPs on which GSMR can perform a reliable analysis), the GWS threshold was
lowered to 1×10−5, allowing a sufficient number of SNPs to conduct the reverse GSMR
analysis for former smoker status, autism, and intracranial volume.

Author Manuscript

The method estimates a putative causal effect of the exposure on the outcome (bxy) as a
function of the relationship between the SNPs’ effects on the exposure (bzx) and the SNPs’
effects on the outcome (bzy), given the assumption that the effect of non-pleiotropic SNPs on
an exposure (x) should be related to their effect on the outcome (y) in an independent sample
only via mediation through the phenotypic causal pathway (bxy). The estimated causal effect
coefficients (bxy) are approximately equal to the natural log odds ratio (OR) for a casecontrol trait29. An OR of 2 can be interpreted as a doubled risk compared to the population
prevalence of a binary trait for every SD increase in the exposure trait. For quantitative traits
the bxy can be interpreted as a one standard deviation increase explained in the outcome trait
for every SD increase in the exposure trait. This method can help differentiate the likely
causal direction of association between two traits but cannot make any statement about the
intermediate mechanisms involved in any potential causal process.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SNP-based associations with intelligence in the GWAS meta-analysis of N=269,867
independent individuals.

(a) Manhattan plot showing the −log10 transformed two-tailed P-value of each SNP from
the GWAS meta-analysis (of linear and logistic regression statistics) on the y-axis and base
pair positions along the chromosomes on the x-axis. The dotted red line indicates
Bonferroni-corrected genome-wide significance (P<5×10−8); the blue line the threshold for
suggestive associations (P<1×10−5). Independent lead SNPs are indicated by a diamond. (b)
Heritability enrichment of 28 functional annotation categories for SNPs in the meta-analysis,
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calculated with stratified LD score regression. Error bars show 95% confidence intervals
around the enrichment estimate. The dashed horizontal line indicates no enrichment of the
annotation category. Red dots indicate significant Bonferroni-corrected two-tailed P-values
and beige dots indicate suggestive (P<.05) values. UTR=untranslated region;
TSS=transcription start site; CTCF=CCCTC-binding factor; DHS=DNaseI Hypersensitive
Site; TFBS=transcription factor binding site; DGF=DNaseI digital genomic footprint. (c)
Distribution of functional consequences of SNPs in genomic risk loci in the meta-analysis.
(d) Distribution of RegulomeDB score for SNPs in genomic risk loci, with a low score
indicating a higher likelihood of having a regulatory function (Online methods). (e) The
minimum chromatin state across 127 tissue and cell types for SNPs in genomic risk loci,
with lower states indicating higher accessibility and states 1–7 referring to open chromatin
states (Online Methods).

Author Manuscript
Author Manuscript
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2019 March 11.

Savage et al.

Page 21

Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript

Figure 2. Cross-locus interactions for genomic regions associated with intelligence in 269,867
independent individuals.

Circos plots showing genes on chromosomes 2 (a), 5 (b), 6 (c), 9 (d), and 22 (e) that were
linked to genomic risk loci in the GWAS meta-analysis (blue regions) by eQTL mapping
(green lines connecting an eQTL SNP to its associated gene), and/or chromatin interactions
(orange lines connecting two interacting regions) and showed evidence of interaction across
two independent genomic risk loci. Genes implicated by eQTL are in green, by chromatin
interactions in orange, and by both eQTL and chromatin interactions mapping in red. The
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outer layer shows a Manhattan plot containing the −log10 transformed two-tailed P-value of
each SNP from the GWAS meta-analysis (of linear and logistic regression statistics), with
genome-wide significant SNPs colored according to linkage disequilibrium patterns with the
lead SNP. Circos plots for all chromosomes are provided in Supplementary Fig. 8.
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Figure 3. Implicated genes, pathways, and tissue- and cell- expression profiles for intelligence in
269,867 independent individuals.
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(a) Manhattan plot of the genome-wide gene-based association analysis (GWGAS). The yaxis shows the −log10 transformed two-tailed P-value of each gene from a linear model, and
the chromosomal position on the x-axis. The red dotted line indicates the Bonferronicorrected threshold for genome-wide significance of the gene-based test (P<2.76×10−6;
0.05/18,128 genes), and the blue line indicates the suggestive threshold (P<2.76×10−5;
0.5/18,128 genes) (b) Venn diagram showing overlap of genes implicated by positional
mapping, eQTL mapping, chromatin interaction mapping, and GWGAS. (c) Gene
expression profiles of associated genes in 53 tissue types. The y-axis shows the −log10
transformed two-tailed P-value of association of GWGAS test statistics with tissue-specific
gene expression levels in a linear model. Expression data were extracted from the GenotypeTissue Expression (GTEx) database. Expression values (RPKM) were log2 transformed with
pseudocount 1 after winsorization at 50 and averaged per tissue. The dotted blue line
indicates the Bonferroni-corrected significance threshold (P=0.05/7,323 genesets=6.83×10−6). (d) Single-cell gene-expression analysis of genes related to intelligence in
24 cell-types. The x-axis shows the −log10 transformed two-tailed P-value of association of
GWGAS test statistics with cell-specific gene expression levels in a linear model. The dotted
blue line indicates the Bonferroni-corrected significance threshold (P=0.05/7,323 genesets=6.83×10−6).
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Overview of cohorts included in a GWAS meta-analysis of general intelligence.
Cohort

N

Age

195,653

39–72

Verbal and mathematical reasoning

35,289

8–96

One or more neuropsychological tests from three or more domains of cognitive
performance

3. RS

6,182

45–98

Letter-digit substitution, Stroop, verbal fluency, delayed recall

4. GENR

1,929

5–9

SON-R (spatial visualization and abstract reasoning subsets)

5. STR

3,215

18

Logical, verbal, spatial, and technical ability subtests

6. S4S

2,818

17–18

7. HiQ / HRS

9,410

*

High IQ cases / unselected population controls

8. TEDS

3,414

12

WISC-III verbal and nonverbal reasoning; Raven's progressive matrices

9a. DTR - MADT

737

55–80

Verbal fluency, digit span, immediate and delayed recall tests

9b. DTR - LSADT

253

73–94

Verbal fluency, digit span, immediate and delayed recall tests

1. UKB
2. COGENT

Author Manuscript

10. IMAGEN
11a. BLTS - Children
11b. BLTS - Adolescents
12. NESCOG
13. GfG

Phenotype

SAT test scores

1,343

14

530

12–13

WISC-IV, CANTAB factor score
VSRT-C factor score

2,598

15–30

MAB-II IQ score

252

18–79

WAIS IQ score

5,084

15–91

ICAR verbal reasoning test

14a. STSA - SATSA+GENDER

703

50–94

Verbal, spatial, episodic memory, and processing speed tests

14b. STSA - HARMONY

448

65–96

Verbal, spatial, episodic memory, and processing speed tests

*

HiQ/HRS sample used a case-control design rather than a cognitive test score ascertained at a specific age; see Online Methods and
Supplementary information 1.1.
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